This is Another Opportunity to Go Behind The Curtain Formerly Reserved For Elites

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email. [Cannabis Profits Daily] Sunday, December 2, 2018 This is Another Opportunity to Go Behind The Curtain Formerly Reserved For The Elites By Greg Miller I was just going over the portfolio I've curated for our [Cannabis Investor's Report]( members, and it reminded me of one of the things I like most about what we've created here at the National Institute for Cannabis Investors. One of our picks gets our members into the world of angel investing. It's very rare that everyday investors in America get an opportunity to become an angel investor. This has long been something in which only the wealthiest 2% could take part. I've found that [cannabis investing can be different]( - And one company I recommended to investors proves that point more than any. In a way, this is the Institute's way of pulling back the curtain for people who didn't have opportunities and access in these rarest of situations in the past. It reminds me of something my colleague and renowned pattern trader Tom Gentile is getting ready to do. He sold his first trading breakthrough for tens of millions of dollars. He thinks his next breakthrough - "Alpha-9" - could be worth 10 times that. Part supercomputer, part artificial intelligence, part sequence-matching protocol, Alpha-9 is designed to generate daily plays that all have the potential to double their initial investment. This time, he's not selling his strategy to Wall Street. Instead, he's letting ordinary investors in on the breakthrough first. He'll be broadcasting it live to investors on December 6 at 1 p.m. (EST). This is Tom's way of pulling back the curtain. And as a member of Cannabis Profits Daily, you are welcome to attend for free. Just [click here to secure your spot now](. Greg Miller Executive Director, National Institute for Cannabis Investors P.S.: [The most exciting cannabis IPO opportunity we've seen this year]( is about to hit the markets within days. You need to know about this company now, before other investors are scrambling to play catch-up once this stock is making big gains in its earliest days of trading. Find out about it [right here](. This Industry Has Minted Millionaires Before (Today, It Could Be Your Turn) What former Speaker of the House John Boehner has revealed about the cannabis industry could help you make a FORTUNE from America's next trillion-dollar industry. If you missed this shocking prediction live, [go here for a special rebroadcast](. [Investors Are Losing Thousands By Looking At These Misleading Numbers]( There is a reason the adage "you get what you pay for" exists. Dozens of financial information websites put out a lot of misleading information, especially when it comes to cannabis companies that are new or making a lot of deals. [Click here]( to read the shocking realization we had and what we've done to fix the problem for marijuana investors... [Every Cannabis Investor Should Be Using This Invaluable Tool]( Over the years, the team here at NICI has noticed a trend. If you want to beat Wall Street, if you want to trade like America's elite, you need to have this one invaluable tool in your arsenal. Not only does it help you cut through the market noise, it also helps pinpoint the most lucrative profit opportunities in the game. And if you [click here]( we can show you how you can get this powerful investing tool at your fingertips. [Big Pharma Doesn't Want You to Know What Secret Competitor Will Squeeze Its Cannabis Profits]( Epidiolex may be the first FDA-approved, cannabis-based pharma product on the market. But a competitor will take a large bite out of that market as it continues to show similar effects as the prescription-based brand. Follow [this link]( to find out more... --------------------------------------------------------------- You are receiving this e-mail at {EMAIL}, as a part of your subscription. Remove your email from this list: [Unsubscribe]( © 2018 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 [Contact Customer Service](mailto:support@nicinvestors.com?subject=Cannabis%20Profits%20Daily%20Question) Website: []( Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. [Privacy Policy]( | [Terms & Conditions](